Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Ares Capital upgraded to Buy on NAV gains at Janney Montgomery Scott » 10:27
10/27/20
10/27
10:27
10/27/20
10:27
ARCC

Ares Capital

$14.22 /

+0.205 (+1.46%)

As previously reported,…

As previously reported, Janney Montgomery Scott analyst Mitchel Penn upgraded Ares Capital to Buy from Neutral with a fair value estimate of $16.50, up from $14, to reflect the recent gain in net asset value, or NAV, and the company's quarterly report. A portion of the company's unrealized losses taken in Q1 have been reversed, consistent with the credit spread narrowing seen in the public capital markets, and Penn has lowered the discount rate he is applying as the level of uncertainty from COVID has declined, the analyst added.

ShowHide Related Items >><<
ARCC Ares Capital
$14.22 /

+0.205 (+1.46%)

10/27/20 Janney Montgomery Scott
Ares Capital upgraded to Buy from Neutral at Janney Montgomery Scott
08/05/20 Citi
Ares Capital price target raised to $17 from $15 at Citi
05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
ARCC Ares Capital
$14.22 /

+0.205 (+1.46%)

ARCC Ares Capital
$14.22 /

+0.205 (+1.46%)

Upgrade
Ares Capital upgraded to Buy from Neutral at Janney Montgomery Scott » 10:17
10/27/20
10/27
10:17
10/27/20
10:17
ARCC

Ares Capital

$14.20 /

+0.185 (+1.32%)

Janney Montgomery Scott…

Janney Montgomery Scott upgraded Ares Capital to Buy from Neutral.

ShowHide Related Items >><<
ARCC Ares Capital
$14.20 /

+0.185 (+1.32%)

08/05/20 Citi
Ares Capital price target raised to $17 from $15 at Citi
05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
ARCC Ares Capital
$14.20 /

+0.185 (+1.32%)

ARCC Ares Capital
$14.20 /

+0.185 (+1.32%)

Earnings
Ares Capital reports Q3 core EPS 39c, consensus 38c » 07:24
10/27/20
10/27
07:24
10/27/20
07:24
ARCC

Ares Capital

$14.02 /

-0.015 (-0.11%)

Reports Q3 NII per share…

Reports Q3 NII per share 39c vs. 50c last year. "We reported another strong quarter of core and GAAP earnings driven by stable credit performance, modestly improving corporate profitability and higher asset prices," said Kipp deVeer, CEO of Ares Capital. "With our extensive footprint, deep market relationships and a modestly improving economic outlook, we are seeing a material pickup in investment activity and high-quality investment opportunities."

ShowHide Related Items >><<
ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

08/05/20 Citi
Ares Capital price target raised to $17 from $15 at Citi
05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

Over a month ago
Conference/Events
Jefferies to hold a virtual summit » 08:20
09/09/20
09/09
08:20
09/09/20
08:20
AINV

Apollo Investment

$8.84 /

-0.05 (-0.56%)

, ARCC

Ares Capital

$14.16 /

+0.07 (+0.50%)

, BBDC

Barings BDC

$8.16 /

+0.2 (+2.51%)

, CPTA

Capitala Finance

$9.83 /

+0.03 (+0.31%)

, CSWC

Capital Southwest

$14.61 /

+0.39 (+2.74%)

, FSK

FS KKR Capital

$15.90 /

-0.22 (-1.36%)

, GAIN

Gladstone Investment

$9.29 /

+0.05 (+0.54%)

, HTGC

Hercules Capital

$11.14 /

+0.22 (+2.01%)

, OCSL

Oaktree Specialty Lending

$4.95 /

+0.005 (+0.10%)

, PNNT

PennantPark

$3.66 /

+0.115 (+3.24%)

Inaugural US BDC Virtual…

Inaugural US BDC Virtual Summit will be held on September 9.

ShowHide Related Items >><<
PNNT PennantPark
$3.66 /

+0.115 (+3.24%)

OCSL Oaktree Specialty Lending
$4.95 /

+0.005 (+0.10%)

HTGC Hercules Capital
$11.14 /

+0.22 (+2.01%)

GAIN Gladstone Investment
$9.29 /

+0.05 (+0.54%)

FSK FS KKR Capital
$15.90 /

-0.22 (-1.36%)

CSWC Capital Southwest
$14.61 /

+0.39 (+2.74%)

CPTA Capitala Finance
$9.83 /

+0.03 (+0.31%)

BBDC Barings BDC
$8.16 /

+0.2 (+2.51%)

ARCC Ares Capital
$14.16 /

+0.07 (+0.50%)

AINV Apollo Investment
$8.84 /

-0.05 (-0.56%)

AINV Apollo Investment
$8.84 /

-0.05 (-0.56%)

05/22/20 BMO Capital
Apollo Investment price target lowered to $11 from $16 at BMO Capital
05/22/20 Citi
Apollo Investment downgraded to Sell from Neutral at Citi
03/27/20 Raymond James
Apollo Investment downgraded to Market Perform at Raymond James
03/27/20 Raymond James
Apollo Investment downgraded to Market Perform from Outperform at Raymond James
ARCC Ares Capital
$14.16 /

+0.07 (+0.50%)

08/05/20 Citi
Ares Capital price target raised to $17 from $15 at Citi
05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
BBDC Barings BDC
$8.16 /

+0.2 (+2.51%)

08/18/20
Fly Intel: Top five analyst upgrades
08/17/20 Keefe Bruyette
Barings BDC upgraded to Outperform from Market Perform at Keefe Bruyette
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
06/24/20 Raymond James
Barings BDC upgraded to Strong Buy from Outperform at Raymond James
CPTA Capitala Finance
$9.83 /

+0.03 (+0.31%)

05/26/20
Fly Intel: Top five analyst downgrades
05/26/20 JMP Securities
Capitala Finance downgraded to Underperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Capitala downgraded to Underperform from Market Perform at JMP Securities
10/20/19 Keefe Bruyette
Capitala downgraded to Underperform from Market Perform at Keefe Bruyette
CSWC Capital Southwest
$14.61 /

+0.39 (+2.74%)

06/04/20 JMP Securities
Capital Southwest price target lowered to $17 from $22.50 at JMP Securities
03/17/20 National Securities
Capital Southwest upgraded to Buy from Neutral at National Securities
03/03/20 National Securities
Capital Southwest downgraded to Neutral from Buy at National Securities
12/12/19 Raymond James
Capital Southwest initiated with an Outperform at Raymond James
FSK FS KKR Capital
$15.90 /

-0.22 (-1.36%)

08/11/20 Compass Point
Compass Point downgrades FS KKR Capital to Neutral after $16.50 target reached
08/11/20 Compass Point
FS KKR Capital downgraded to Neutral from Buy at Compass Point
08/03/20 JPMorgan
FS KKR Capital downgraded to Neutral on valuation at JPMorgan
08/03/20 JPMorgan
FS KKR Capital downgraded to Neutral from Overweight at JPMorgan
GAIN Gladstone Investment
$9.29 /

+0.05 (+0.54%)

03/05/20 National Securities
Gladstone Investment initiated with a Neutral at National Securities
02/06/20 Wedbush
Gladstone Investment downgraded to Neutral from Outperform at Wedbush
HTGC Hercules Capital
$11.14 /

+0.22 (+2.01%)

07/31/20 Compass Point
Hercules upgraded to Buy on credit performance at Compass Point
07/31/20 Compass Point
Hercules Capital upgraded to Buy from Neutral at Compass Point
07/20/20 Piper Sandler
Hercules Capital assumed with an Overweight at Piper Sandler
06/19/20 Janney Montgomery Scott
Hercules Capital upgraded to Buy at Janney Montgomery Scott
OCSL Oaktree Specialty Lending
$4.95 /

+0.005 (+0.10%)

06/19/20 Janney Montgomery Scott
Oaktree Specialty Lending upgraded to Buy at Janney Montgomery Scott
06/19/20 Janney Montgomery Scott
Oaktree Specialty Lending upgraded to Buy from Neutral at Janney Montgomery Scott
03/05/20 National Securities
Oaktree Specialty Lending initiated with a Buy at National Securities
01/15/20
Fly Intel: Top five analyst upgrades
PNNT PennantPark
$3.66 /

+0.115 (+3.24%)

10/29/19 JPMorgan
JPMorgan downgrades PennantPark to Underweight, trims target to $6
10/29/19 JPMorgan
PennantPark downgraded to Underweight from Neutral at JPMorgan
PNNT PennantPark
$3.66 /

+0.115 (+3.24%)

OCSL Oaktree Specialty Lending
$4.95 /

+0.005 (+0.10%)

HTGC Hercules Capital
$11.14 /

+0.22 (+2.01%)

GAIN Gladstone Investment
$9.29 /

+0.05 (+0.54%)

FSK FS KKR Capital
$15.90 /

-0.22 (-1.36%)

CSWC Capital Southwest
$14.61 /

+0.39 (+2.74%)

CPTA Capitala Finance
$9.83 /

+0.03 (+0.31%)

BBDC Barings BDC
$8.16 /

+0.2 (+2.51%)

ARCC Ares Capital
$14.16 /

+0.07 (+0.50%)

AINV Apollo Investment
$8.84 /

-0.05 (-0.56%)

CSWC Capital Southwest
$14.61 /

+0.39 (+2.74%)

CSWC Capital Southwest
$14.61 /

+0.39 (+2.74%)

ARCC Ares Capital
$14.16 /

+0.07 (+0.50%)

Over a quarter ago
Recommendations
Ares Capital price target raised to $17 from $15 at Citi » 06:28
08/05/20
08/05
06:28
08/05/20
06:28
ARCC

Ares Capital

$14.53 /

+0.09 (+0.62%)

Citi analyst Arren…

Citi analyst Arren Cyganovich raised the firm's price target on Ares Capital to $17 from $15 and keeps a Buy rating on the shares following the company's Q2 results. The quarter highlight Ares Capital's portfolio management expertise and its ability to maintain solid liquidity during stressed periods, Cyganovich tells investors in a research note.

ShowHide Related Items >><<
ARCC Ares Capital
$14.53 /

+0.09 (+0.62%)

ARCC Ares Capital
$14.53 /

+0.09 (+0.62%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
ARCC Ares Capital
$14.53 /

+0.09 (+0.62%)

ARCC Ares Capital
$14.53 /

+0.09 (+0.62%)

Options
Unusually active option classes on open August 4th » 09:40
08/04/20
08/04
09:40
08/04/20
09:40
PSTG

Pure Storage

$18.11 /

+ (+0.00%)

, ARCC

Ares Capital

$14.44 /

+ (+0.00%)

, ADT

ADT Inc.

$13.42 /

+ (+0.00%)

, BP

BP

$22.09 /

+ (+0.00%)

, VALE

Vale

$11.43 /

+ (+0.00%)

, AZN

AstraZeneca

$56.80 /

+ (+0.00%)

, INTC

Intel

$48.29 /

+ (+0.00%)

, PINS

Pinterest

$36.07 /

+ (+0.00%)

, MO

Altria Group

$41.00 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Pure Storage (PSTG), Ares Capital (ARCC), ADT (ADT), ProShares VIX Short Term Futures (VIXY), BP (BP), Vale (VALE), AstraZeneca (AZN), Intel (INTC), Pinterest (PINS), and Altria Group (MO).

ShowHide Related Items >><<
VALE Vale
$11.43 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

06/18/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
06/17/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
05/29/20 Lake Street
Pure Storage a share gainer with 'robust' subscription growth, says Lake Street
05/29/20 Northland
Pure Storage price target raised to $23 from $21 at Northland
ARCC Ares Capital
$14.44 /

+ (+0.00%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
ADT ADT Inc.
$13.42 /

+ (+0.00%)

08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded at William Blair on ADT/Google overhang
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
BP BP
$22.09 /

+ (+0.00%)

07/16/20 Jefferies
BP upgraded to Buy from Hold at Jefferies
07/15/20 JPMorgan
BP price target raised to 425 GBp from 400 GBp at JPMorgan
07/14/20 Credit Suisse
BP price target lowered to 350 GBp from 360 GBp at Credit Suisse
07/01/20 Barclays
BP price target raised to 400 GBp from 380 GBp at Barclays
VALE Vale
$11.43 /

+ (+0.00%)

06/11/20 Deutsche Bank
Vale price target raised to $13 from $11 at Deutsche Bank
06/09/20 GLJ Research
Fortescue Metals upgraded to Hold from Sell at GLJ Research
06/05/20 Exane BNP Paribas
Vale upgraded to Outperform from Neutral at Exane BNP Paribas
06/03/20 UBS
Vale upgraded to Buy from Neutral at UBS
AZN AstraZeneca
$56.80 /

+ (+0.00%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
INTC Intel
$48.29 /

+ (+0.00%)

08/04/20 Jefferies
AMD price target raised to $95 from $86 at Jefferies
08/03/20 Roth Capital
MaxLinear price target raised to $35 from $30 at Roth Capital
08/03/20 Stifel
Stifel rises MaxLinear price target to $35 after completion of Home Gateway deal
07/31/20 Erste Group
Intel downgraded to Hold from Buy at Erste
PINS Pinterest
$36.07 /

+ (+0.00%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
08/03/20 JPMorgan
Pinterest price target raised to $37 from $26 at JPMorgan
MO Altria Group
$41.00 /

+ (+0.00%)

07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Barclays
Altria downgraded to Equal Weight on share losses at Barclays
07/08/20 Barclays
Altria Group downgraded to Equal Weight from Overweight at Barclays
07/07/20 Stifel
IQOS reduced exposure claim a 'win' for Philip Morris, Altria, says Stifel
VALE Vale
$11.43 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

  • 16
    Oct
VALE Vale
$11.43 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

Earnings
Ares Capital reports Q2 Core EPS 39c, consensus 38c » 07:42
08/04/20
08/04
07:42
08/04/20
07:42
ARCC

Ares Capital

$14.44 /

+0.34 (+2.41%)

Reports Q2 NII per share…

Reports Q2 NII per share 39c vs. 49c last year. "Despite the difficulty our economy is experiencing from the global pandemic, we delivered strong second quarter core and GAAP earnings with growth in our net asset value," said Kipp deVeer, Chief Executive Officer of Ares Capital. "Our portfolio of primarily defensive, high quality, upper middle market companies remains well positioned, and we believe that the broad capabilities of our team and our available liquidity will enable us to capitalize on the improving market environment for new investments."

ShowHide Related Items >><<
ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

ARCC Ares Capital
$14.44 /

+0.34 (+2.41%)

Options
Largest borrow rate increases among liquid names » 08:45
06/16/20
06/16
08:45
06/16/20
08:45
EMAN

eMagin

$1.04 /

+0.1349 (+14.90%)

, PYX

Pyxus

$2.93 /

+ (+0.00%)

, NXPI

NXP Semiconductors

$109.50 /

+3.35 (+3.16%)

, PEI

Pennsylvania REIT

$1.48 /

-0.025 (-1.66%)

, DNR

Denbury Resources

$0.44 /

-0.0169 (-3.67%)

, APT

Alpha Pro Tech

$12.75 /

+0.28 (+2.25%)

, SRNE

Sorrento Therapeutics

$4.88 /

+0.255 (+5.52%)

, ARCC

Ares Capital

$15.08 /

+0.295 (+2.00%)

, TAK

Takeda Pharmaceutical

$18.38 /

-0.09 (-0.49%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: eMagin (EMAN) 42.69% +2.75, Pyxus International (PYX) 134.68% +2.44, NXP Semiconductors (NXPI) 2.50% +1.82, Direxion Oil & Gas 3x Bear ETF (DRIP) 16.45% +1.27, Pennsylvania REIT (PEI) 70.35% +0.60, Denbury Resources (DNR) 27.57% +0.33, Alpha Pro Tech (APT) 82.28% +0.23, Sorrento Therapeutics (SRNE) 26.74% +0.23, Ares Capital (ARCC) 0.58% +0.21, and Takeda Pharmaceutical (TAK) 0.80% +0.19.

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

SRNE Sorrento Therapeutics
$4.88 /

+0.255 (+5.52%)

PYX Pyxus
$2.93 /

+ (+0.00%)

PEI Pennsylvania REIT
$1.48 /

-0.025 (-1.66%)

NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

EMAN eMagin
$1.04 /

+0.1349 (+14.90%)

DNR Denbury Resources
$0.44 /

-0.0169 (-3.67%)

ARCC Ares Capital
$15.08 /

+0.295 (+2.00%)

APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

EMAN eMagin
$1.04 /

+0.1349 (+14.90%)

08/14/19
eMagin downgraded to Hold at Craig-Hallum
08/13/19 Craig-Hallum
eMagin downgraded to Hold from Buy at Craig-Hallum
PYX Pyxus
$2.93 /

+ (+0.00%)

08/27/19 Imperial Capital
Pyxus shares offer four times upside potential, says Imperial Capital
06/25/19
Fly Intel: Top five analyst initiations
06/25/19 Imperial Capital
Pyxus initiated with an Outperform at Imperial Capital
NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

06/08/20
Fly Intel: Top five analyst upgrades
06/08/20 Evercore ISI
NXP Semiconductors upgraded to Outperform from In Line at Evercore ISI
04/29/20 Loop Capital
NXP Semiconductors price target lowered to $125 from $145 at Loop Capital
04/29/20 BMO Capital
NXP Semiconductors price target lowered to $115 from $125 at BMO Capital
PEI Pennsylvania REIT
$1.48 /

-0.025 (-1.66%)

03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
01/16/20 Truist
Pennsylvania REIT downgraded to Sell from Hold at SunTrust
01/15/20 Truist
Pennsylvania REIT downgraded to Sell from Hold at SunTrust
09/23/19 Citi
Pennsylvania REIT downgraded to Sell from Neutral at Citi
DNR Denbury Resources
$0.44 /

-0.0169 (-3.67%)

03/31/20 Stifel
Denbury Resources downgraded to Sell from Hold at Stifel
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Denbury Resources downgraded to Underweight from Equal Weight at Stephens
APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

SRNE Sorrento Therapeutics
$4.88 /

+0.255 (+5.52%)

05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
ARCC Ares Capital
$15.08 /

+0.295 (+2.00%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
03/25/20 Stifel
Molecular Templates initiated with a Buy at Stifel
02/25/20 Stifel
Iovance among 'more interesting' cell therapy takeout candidates, says Stifel
TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

PEI Pennsylvania REIT
$1.48 /

-0.025 (-1.66%)

NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

EMAN eMagin
$1.04 /

+0.1349 (+14.90%)

DNR Denbury Resources
$0.44 /

-0.0169 (-3.67%)

ARCC Ares Capital
$15.08 /

+0.295 (+2.00%)

APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

SRNE Sorrento Therapeutics
$4.88 /

+0.255 (+5.52%)

PYX Pyxus
$2.93 /

+ (+0.00%)

NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

DNR Denbury Resources
$0.44 /

-0.0169 (-3.67%)

APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

SRNE Sorrento Therapeutics
$4.88 /

+0.255 (+5.52%)

PYX Pyxus
$2.93 /

+ (+0.00%)

PEI Pennsylvania REIT
$1.48 /

-0.025 (-1.66%)

NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

TAK Takeda Pharmaceutical
$18.38 /

-0.09 (-0.49%)

SRNE Sorrento Therapeutics
$4.88 /

+0.255 (+5.52%)

PYX Pyxus
$2.93 /

+ (+0.00%)

PEI Pennsylvania REIT
$1.48 /

-0.025 (-1.66%)

NXPI NXP Semiconductors
$109.50 /

+3.35 (+3.16%)

EMAN eMagin
$1.04 /

+0.1349 (+14.90%)

DNR Denbury Resources
$0.44 /

-0.0169 (-3.67%)

APT Alpha Pro Tech
$12.75 /

+0.28 (+2.25%)

Recommendations
Ares Capital price target raised to $15 from $13 at Citi » 06:33
05/07/20
05/07
06:33
05/07/20
06:33
ARCC

Ares Capital

$13.19 /

+0.49 (+3.86%)

Citi analyst Arren…

Citi analyst Arren Cyganovich raised the firm's price target on Ares Capital to $15 from $13 and keeps a Buy rating on the shares following the company's Q1 results. Ares appears well positioned to weather the economic weakness caused by the COVID-19 pandemic with significant liquidity and relationships with its portfolio company private equity sponsors, Cyganovich tells investors in a research note.

ShowHide Related Items >><<
ARCC Ares Capital
$13.19 /

+0.49 (+3.86%)

04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
Earnings
Ares Capital reports Q1 core EPS 41c, consensus 43c » 07:18
05/05/20
05/05
07:18
05/05/20
07:18
ARCC

Ares Capital

$12.40 /

+0.01 (+0.08%)

Reports Q1 NII 54c per…

Reports Q1 NII 54c per share. "With the extreme market volatility and economic disruption caused by the COVID-19 pandemic, we are relying on the deep knowledge, experienced team and proven investment philosophy that we have developed over the past 15 years as a public company," said Kipp deVeer, CEO of Ares Capital. "We believe we are operating from a position of relative strength as our portfolio is defensively positioned and has held up relatively well with a modest level of non-accruing loans. With our significant liquidity of more than $2.6 billion, we have the ability to support our existing borrowers and invest in increasingly attractive market conditions. We declared our second quarter cash dividend of 40c per share and expect to maintain a stable dividend for the foreseeable future."

ShowHide Related Items >><<
ARCC Ares Capital
$12.40 /

+0.01 (+0.08%)

04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.